Observations reveal that radionuclide half-life and energy transfer impact the IFN1 response, suggesting implications for radiopharmaceutical use in tumors.
Tumor Ifnb1 expression following 225Ac-NM600+ICI is not affected by loss of STING expression in tumor or host.
No takes yet. Share an insight, caveat, or question.
Kerr et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: